n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors

The Risk and Prevention Study Collaborative Group·2013·New England Journal of Medicine
DOI 10.1056/nejmoa1205409

Cited by (511)

Items 301–400 of 511

  1. Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patients
    Pei‐Chi Huang, Hsuan Cheng, Yu‐Ting Su, Meng‐Chuan Huang, Chih‐Cheng Hsu, Shang‐Jyh Hwang, Shyi‐Jang Shin, Wen‐Tsan Chang · 2022 · Journal of Diabetes Investigation
  2. Omega-3 and Prostate Cancer: Examining the Pertinent Evidence
    Mark Frederick McCarty, James J. DiNicolantonio, Carl J. Lavie, James Henry O’Keefe · 2014 · Mayo Clinic Proceedings
  3. Addition of marine omega-3 fatty acids to statins in familial hypercholesterolemia does not affect in vivo or in vitro endothelial function
    Liv Nesse Hande, Hilde Thunhaug, Terje Enebakk, Judith Krey Ludviksen, Kristin Pettersen, Anders Hovland, Knut Tore Lappegård · 2019 · Journal of clinical lipidology
  4. Prostate cancer risk and omega-3 Fatty Acid intake from fish oil: a closer look at media messages versus research findings.
    Walter Alexander · 2013 · Europe PMC (PubMed Central)
  5. Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis.
    Shujin Guo, Liuqun Jia, Qian-Jing Hu, Hong-Yu Long, Caishuang Pang, Fuqiang Wen · 2014 · Europe PMC (PubMed Central)
  6. Individual Fatty Acids in Cardiometabolic Disease
    Rajiv Chowdhury, Marinka Steur, Pinal S. Patel, Oscar H. Franco · 2016 · Elsevier eBooks
  7. The pro- or antiarrhythmic actions of polyunsaturated fatty acids and of cholesterol
    Ruben Coronel · 2017 · Pharmacology & Therapeutics
  8. Omega-3 nutraceuticals, climate change and threats to the environment: The cases of Antarctic krill and Calanus finmarchicus
    Alfonso Prado‐Cabrero, John M. Nolan · 2021 · AMBIO
  9. Dietary fatty acids and CHD: from specific recommendations to dietary patterns
    Jacques Delarue · 2021 · Nutrition Research Reviews
  10. n–3 Fatty Acids in Patients with Cardiac Risk Factors
    Maria Carla Roncaglioni, Massimo Tombesi, Maria Giuseppina Silletta · 2013 · New England Journal of Medicine
  11. Omega-3 and risk of atrial fibrillation: vagally-mediated double-edged sword
    O'Keefe, Evan L., O'Keefe, James H., Abuissa, Hussam, Metzinger, Mark, Murray, Ellen, Franco, Grant, Lavie, Carl J., Harris, William S. · 2025 · Progress in Cardiovascular Diseases
  12. Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort
    Marleen A. H. Lentjes, Ruth H. Keogh, Ailsa A. Welch, Angela A. Mulligan, Robert Luben, Nicholas J. Wareham, Kay‐Tee Khaw · 2017 · BMJ Open
  13. Highly Purified Eicosapentaenoic Acid Alleviates the Inflammatory Response and Oxidative Stress in Macrophages during Atherosclerosis via the miR‐1a‐3p/sFRP1/Wnt/PCP‐JNK Pathway
    Tongtong Zang, Han Chen, Shutong Shen, Fei Xu, Rui Wang, Jia Yin, Xiehui Chen, Min Guan, Li Shen, Haobo Pan et al. · 2022 · Oxidative Medicine and Cellular Longevity
  14. Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practice
    Giuseppe Derosa, Pamela Maffioli · 2014 · Expert Review of Endocrinology & Metabolism
  15. Association of Total Marine Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acids, With Aortic Stiffness in Koreans, Whites, and Japanese Americans
    Akira M Sekikawa, Chol Shin, Kamal Masaki, Emma Barinas‐Mitchell, Nobutaka Hirooka, Bradley J. Willcox, Jina Choo, J. White, R. W. Evans, Akira Fujiyoshi et al. · 2013 · American Journal of Hypertension
  16. Lipid-Modifying Drugs: Pharmacology and Perspectives
    Rui-Xia Xu, Yongjian Wu · 2020 · Advances in experimental medicine and biology
  17. Dietary fatty acids in health and disease
    Philip C. Calder, Richard Joseph Deckelbaum · 2014 · Current Opinion in Clinical Nutrition & Metabolic Care
  18. Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up
    Pekka T Mäntyselkä, LEO K. NISKANEN, Hannu Kautiainen, Juha T Saltevo, Peter Würtz, Pasi Soininen, Antti J. Kangas, Mika Ala‐Korpela, Mauno J. Vanhala · 2014 · Lipids in Health and Disease
  19. Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study
    James N Kiage, Uchechukwu K.A. Sampson, Loren P. Lipworth, Sergio Fazio, George A. Mensah, Qilu Yu, Heather M. Munro, Elvis A. Akwo, Qi Dai, William J. Blot et al. · 2015 · Nutrition Metabolism and Cardiovascular Diseases
  20. Mediterranean Diet and Its Protective Mechanisms against Cardiovascular Disease: An Insight into Platelet Activating Factor (PAF) and Diet Interplay
    Paraskevi Detopoulou, Smaragdi Antonopoulou · 2015
  21. Effects of eicosapentaenoic acid and docosahexaenoic acid on lipoproteins in hypertriglyceridemia
    Amish Patel, Matthew Jay Budoff · 2016 · Current Opinion in Endocrinology Diabetes and Obesity
  22. Association of dietary fatty acids and the incidence risk of cardiovascular disease in adults: the Tehran Lipid and Glucose Prospective Study
    Parvin Mirmiran, Zeinab Houshialsadat, Zahra Bahadoran, Sajad Khalili-Moghadam, Farhad Haj Sheikholeslami, Fereidoun Azizi · 2020 · BMC Public Health
  23. Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Yujiro Yokoyama, Toshiki Kuno, Sae X. Morita, Leandro N. Slipczuk, Hisato Takagi, Αlexandros Briasoulis, Azeem Latib, Sripal Bangalore, Sean P. Heffron · 2022 · Journal of Cardiology
  24. Baroreflex sensitivity and central hemodynamics after omega-3 polyunsaturated fatty acids supplementation in an animal model of menopause
    Pasquale Losurdo, Andrea Grillo, Emiliano Panizon, Michela Zanetti, Moreno Bardelli, Gianni Biolo, Bruno Fabris, Renzo Carretta · 2015 · Vascular Pharmacology
  25. Omega-3 Polyunsaturated Fatty Acids Supplements and Cardiovascular Disease Outcome: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
    Qi Xue, Hechen Zhu, Ru Ya, Hao Huang · 2023 · Reviews in Cardiovascular Medicine
  26. The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA
    Robert Block, Amir Abdolahi, Xin Ming Tu, Steve N. Georas, James Thomas Brenna, Richard P. Phipps, Peter Lawrence, Shaker A. Mousa · 2014 · Prostaglandins Leukotrienes and Essential Fatty Acids
  27. Omega-3 fatty acids and the genetic risk of early onset acute coronary syndrome
    Sylvie S.L. Leung Yinko, George Thanassoulis, Ken D. Stark, Meytal Avgil Tsadok, James C. Engert, Louise Pilote · 2014 · Nutrition Metabolism and Cardiovascular Diseases
  28. Dietary ω-3 fatty acids and the incidence of atrial fibrillation in the Million Veteran Program
    Eric T. Guardino, Yanping Li, Xuan‐Mai T. Nguyen, Peter W.F. Wilson, J. Michael Gaziano, Kelly Cho, Emelia J. Benjamin, Luc Djoussé · 2023 · American Journal of Clinical Nutrition
  29. The Moli-sani risk score, a new algorithm for measuring the global impact of modifiable cardiovascular risk factors
    Augusto Filippo Di Castelnuovo, Marialaura Bonaccio, Simona Costanzo, Amalia De Curtis, Mariarosaria Persichillo, Teresa Panzera, Francesca Bracone, Damiano Baldassarre, Maria Carla Roncaglioni, Marta Baviera et al. · 2023 · International Journal of Cardiology
  30. Dislipidemia y riesgo vascular. Una revisión basada en nuevas evidencias
    Vicente Pallarés‐Carratalá, Vicente Pascual Fuster, D V Godoy Rocati · 2015 · Medicina de Familia SEMERGEN
  31. Serum ω-3 Polyunsaturated Fatty Acids and Potential Influence Factors in Elderly Patients with Multiple Cardiovascular Risk Factors
    Wenwen Liu, Xiaochuan Xie, Meilin Liu, Jingwei Zhang, Wenyi Liang, Xiahuan Chen · 2018 · Scientific Reports
  32. Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis
    M. Cabiddu, Alberto Russi, Lucia Appolloni, Daniele Mengato, Marco Chiumente · 2020 · European Journal of Hospital Pharmacy
  33. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials
    Jeongseon Kim, Tung Hoang, Ji‐Myung Kim, So Young Bu, Jeong‐Hwa Choi, Eunju Park, Seung-Min Lee, Eunmi Park, Ji Yeon Min, In Seok Lee et al. · 2020 · Nutrients
  34. Circulating B-Vitamins and Smoking Habits Are Associated with Serum Polyunsaturated Fatty Acids in Patients with Suspected Coronary Heart Disease: A Cross-Sectional Study
    Eli Skeie, Elin Strand, Eva Ringdal Pedersen, Bodil Bjørndal, Pavol Bohov, Rolf Kristian Berge, Gard Frodahl Tveitevåg Svingen, Reinhard Seifert, Per Magne Ueland, Øivind Midttun et al. · 2015 · PLoS ONE
  35. High Consumption of Farmed Salmon Does Not Disrupt the Steady State of Persistent Organic Pollutants (POP) in Human Plasma and Adipose Tissue
    Trygve Hausken, Janneche Utne Skaare, Anuschka Polder, Margaretha A. Haugen, Helle Margrete Meltzer, Anne‐Katrine Lundebye, Kåre Julshamn, Ottar Kjell Nygard, Rolf Kristian Berge, Jon Skorve · 2014 · Journal of Toxicology and Environmental Health
  36. Effect of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) on the regulation of vascular endothelial cell function
    Dominika Łacheta, Wioletta Olejarz, Marta Włodarczyk, Grażyna Nowicka · 2019 · Postępy Higieny i Medycyny Doświadczalnej
  37. Disorders of Lipid Metabolism
    Clay F. Semenkovich, Anne Carol Goldberg, Ira J. Goldberg · 2016 · Elsevier eBooks
  38. Omega-3 fatty acids in the treatment of heart failure
    Matthew Kelling, Michelle Dimza, Alec Bartlett, Dmitry O. Traktuev, Julio D Duarte, Ellen C. Keeley · 2024 · Current Problems in Cardiology
  39. Blood clearance kinetics and organ delivery of medium-chain triglyceride and fish oil-containing lipid emulsions: Comparing different animal species
    Chengming Hu, Huanzhong Ding, Qiulin Zhuang, Pierre Llanos, Thivashnee Pillay, Carlo Hernandez, Yvon Carpentier, Richard Joseph Deckelbaum, Chuchun L. Chang · 2020 · Clinical Nutrition
  40. Effect of n-3 PUFA on left ventricular remodelling in chronic heart failure: a systematic review and meta-analysis
    Jing Liu, Qingshu Meng, Liang Zheng, Ping Yu, Hao Hu, Rulin Zhuang, Xinyu Ge, Zhongmin Liu, Xiaoting Liang, Xiaohui Zhou · 2022 · British Journal Of Nutrition
  41. The effect of omega-3 Polyunsaturated Fatty Acid (PUFA) prescription preparations on the prevention of clinical cardiovascular disease: a meta-analysis of RCTs
    Shujie Dong, Yalan Wang, Jialu Bian, Hongsheng Chen, Jie Dong, Jun Zhu, Tongyan Zhang, Qian Du, Rongsheng Zhao · 2024 · Nutrition Journal
  42. Updated guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists
    Ricky D. Turgeon, Todd J. Anderson, Jean C. Grégoire, Glen J. Pearson · 2014 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
  43. Lost in Translation
    Daniel I. Sessler · 2017 · Anesthesiology
  44. Reprint of: Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease
    Trevor Anthony Mori · 2018 · Fitoterapia
  45. Reducing Cardiovascular Disease Risk in Women Beyond Statin Therapy: New Insights 2020
    Lori J. Mosca, Ann Marie Návar, NANETTE KASS WENGER · 2020 · Journal of Women s Health
  46. Combined Dyslipidemia in Children and Adolescents
    Rae-Ellen Webb Kavey · 2016
  47. Marine-derived n-3 fatty acids therapy for stroke
    Celia Gabriela Alvarez Campano, Mary Joan MacLeod, Lorna S. Aucott, Frank Thiès · 2019 · Cochrane Database of Systematic Reviews
  48. Customized Prevention Trials Could Resolve the Controversy of the Effects of Omega-3 Fatty Acids on Cancer
    Karam El‐Bayoumy, Andrea Manni · 2019 · Nutrition and Cancer
  49. Associations Between Plasma Omega‐3 and Fish Oil Use With Risk of Atrial Fibrillation in the UK Biobank
    Evan L. O’Keefe, James Henry O’Keefe, Nathan Tintle, W Grant Franco, Jason Westra, William Stephen Harris · 2025 · Journal of the American Heart Association
  50. Why Fish Oil Fails: A Comprehensive 21st Century Lipids-Based Physiologic Analysis
    Brian Scott Peskin · 2014 · Journal of Lipids · Retracted
  51. Controversies about the cardiovascular effects of OM3FA. Did inappropriate placebos skew clinical trial results?
    Fernando Martins do Vale, Maria José Diógenes, Henrique Atalaia-Barbacena · 2020 · Pharmacological Research
  52. The effect of omega-3 polyunsaturated fatty acids on stroke treatment and prevention: a systematic review and meta-analysis
    Qian Xu, Lingling Du, Heng Gu, Meng Ji, Ling Zhan · 2022 · Nutrición Hospitalaria
  53. Assessing the Highest Level of Evidence from Randomized Controlled Trials in Omega-3 Research
    Sandhya Sahye‐Pudaruth, David W.L. · 2023 · Nutrients
  54. The Optimal Dosage and Duration of ω-3 PUFA Supplementation in Heart Failure Management: Evidence from a Network Meta-Analysis
    Ping‐Tao Tseng, Bing‐Yan Zeng, Chih-Wei Hsu, Chih‐Sung Liang, Brendon Stubbs, Yen-Wen Chen, Tien‐Yu Chen, Wei‐Te Lei, Jiann-Jy Chen, Yow‐Ling Shiue et al. · 2025 · Advances in Nutrition
  55. Treatment and clinical endpoints in polycythemia vera: seeking the best obtainable version of the truth
    Jason R. Gotlib · 2022 · Blood
  56. Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study
    Junguo Zhang, Anping Cai, Ge Chen, Xiaojie Wang, Miao Cai, Haitao Li, Steven E. Nissen, Gregory Y.H. Lip, Hualiang Lin · 2022 · European Journal of Preventive Cardiology
  57. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter?
    James J. DiNicolantonio, Pascal Meier, James Henry O’Keefe · 2013 · Europe PMC (PubMed Central)
  58. Lipoprotein Metabolism and the Treatment of Lipid Disorders
    Mason Wright Freeman, Geoffrey A. Walford · 2015 · Elsevier eBooks
  59. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial
    Qiang Zeng, Sheng-Yong Dong, Y.-P. Liu, Jun Qiu Fu, Ping Shuai, Zhifeng Zhao, T.-X. Li · 2017 · Nutrition Metabolism and Cardiovascular Diseases
  60. Fish in the Mediterranean diet
    María Molina‐Vega, Ana María Gómez‐Pérez, Francisco José Tinahones · 2020 · Elsevier eBooks
  61. Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment
    Fabien A. Picard, Philippe Gabríel Steg · 2021 · Current Atherosclerosis Reports
  62. Dietary Supplementation with Anti-Inflammatory Omega-3 Fatty Acids for Cardiovascular Protection: Help or Hoax?
    Yichen Li, Zhenquan Jia, Hong Zhu · 2019
  63. Dyslipidemia in Obesity
    Dick C. Chan, Jing Pang, Gerald Francis Watts · 2016 · Springer eBooks
  64. Diet and cardiovascular disease: Dietary patterns, foods and nutrients
    Peter Marshall Clifton, Linda C Tapsell · 2013 · Nutrition & Dietetics
  65. Use of Phytochemicals against Neuroinflammation
    Wei‐Yi Ong, Tahira Farooqui, Christabel Fung‐Yih Ho, Yee‐Kong Ng, A. A. Farooqui · 2017 · Wiley eBooks
  66. Marine N-3 Fatty Acids Mitigate Hyperglycemia in Prediabetes by Improving Muscular Glucose Transporter 4 Translocation and Glucose Homeostasis
    Haoyu Li, Pan Zhuang, Xiaohui Liu, Yin Li, Ao Yang, Yimei Tian, Wei Ping Jia, Yu Zhang, Jingjing Jiao · 2025 · Research
  67. Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia
    Ichiro Tatsuno · 2014 · Expert Review of Cardiovascular Therapy
  68. n-3 fatty acids and the risk of atrial fibrillation, review
    Wolfgang Herrmann, Markus Herrmann · 2024 · Diagnosis
  69. From Science to Finance—A Tool for Deriving Economic Implications from the Results of Dietary Supplement Clinical Studies
    Christopher J. Shanahan, Robert de Lorimier · 2014 · Journal of Dietary Supplements
  70. Prevention of Heart Failure in Patients with Chronic Kidney Disease
    Amr Raghban, Jennifer Kirsop, W.H. Wilson Tang · 2014 · Current Cardiovascular Risk Reports
  71. The return of triglycerides and revival of omega-3 fatty acids!
    Jean Ferrières · 2020 · Archives of cardiovascular diseases
  72. The Emerging Role of Icosapent Ethyl in Patients with Cardiovascular Disease: Mechanistic Insights and Future Applications
    Ashish Gupta, Mohammad Alkhalil · 2023 · Journal of Clinical Medicine
  73. Long chain n-3 polyunsaturated fatty acid intake across the life span for cardiovascular disease prevention in women
    Wendy Louise Hall · 2024 · Proceedings of The Nutrition Society
  74. n-3 Fatty acids and cardiovascular disease: the story is not over yet
    Claudio Bilato · 2013 · Aging Clinical and Experimental Research
  75. Cardiovascular Disease Associated with the Human Immunodeficiency Virus: An Update
    Thomas Stephen Metkus, Todd Tarquin Brown, Wendy S. Post · 2014 · Current Treatment Options in Cardiovascular Medicine
  76. Optimal Dose of n-3 Polyunsaturated Fatty Acids for Cardiovascular Event Prevention
    Yuji Nishizaki, Hiroyuki Daida · 2020 · Circulation Reports
  77. A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States
    Sephy Philip, Sumita Chowdhury, John R Nelson, P. Benjamin Everett, Carolyn K. Hulme-Lowe, Jordana K. Schmier · 2016 · Journal of Medical Economics
  78. The cardiovascular benefits of indiscriminate supplementation of omega-3 fatty acids; meta-analysis and decision-making approach
    Moshe Leshno, Uri Goldbourt, Ilya Pinchuk, Dov A. Lichtenberg · 2017 · International Journal of Food Sciences and Nutrition
  79. Editorial
    Philip C. Calder, Richard Joseph Deckelbaum · 2019 · Current Opinion in Clinical Nutrition & Metabolic Care
  80. Potential and Future Therapeutic Applications of Eicosapentaenoic/Docosahexaenoic Acid and Probiotics in Chronic Low-Grade Inflammation
    Amedeo Amedei, Ingrid Lamminpää, Cinzia Parolini · 2025 · Biomedicines
  81. Are the ratio and amount of n-6 and n-3 fatty acids associated with cardiovascular outcomes?—a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials
    Min‐Jie Cao, Fangwei Yang, Yiwen Guo, Ruijie Liu, Ming Chang, Yandan Wang, Wei Wei, Qingzhe Jin, Xingguo Wang · 2024 · Food Bioscience
  82. JAK2 mutations in polycythemia vera: from molecular origins to inflammatory pathways and clinical implications
    Beatríz Bellosillo, Michael Doubek, Ciprian Tomuleasa, Martin Grießhammer, Monia Marchetti, Tomasz Sacha, Heinz Gisslinger · 2024 · memo - Magazine of European Medical Oncology
  83. Marine-derived n-3 fatty acids therapy for stroke
    Celia Gabriela Alvarez Campano, Mary Joan MacLeod, Lorna S. Aucott, Frank Thiès · 2022 · Cochrane Database of Systematic Reviews
  84. Potential Benefits of Omega-3 Polyunsaturated Fatty Acids (N3PUFAs) on Cardiovascular Health Associated with COVID-19: An Update for 2023
    Louise Weiwei Lu, Siew Young Quek, Shi-Ping Lu, Jie‐Hua Chen · 2023 · Metabolites
  85. ω‑3 fatty acids in atherosclerotic cardiovascular disease (Review)
    Xingxing Xie, Xue Liu, Rong Li, Fan Ling, Fujing Huang · 2024 · Biomedical Reports
  86. Critical review of non-statin treatments for dyslipoproteinemia
    Jing Pang, Dick C. Chan, Gerald Francis Watts · 2014 · Expert Review of Cardiovascular Therapy
  87. The coincidence of increased risk of atrial fibrillation in randomized control trials of omega-3 fatty acids: a meta-analysis
    Chia Siang Kow, Suhail A.R. Doi, Syed Shahzad Hasan · 2021 · Expert Review of Clinical Pharmacology
  88. Effects of omega-3 fatty acid treatment on risk for atrial fibrillation: an updated meta-analysis of 34 trials including 114,326 individuals
    Nada R. Abuknesha, James Henry O’Keefe, Frank Qian, Nathan Tintle, Yidie Lin, Yue Sun, Han‐Zhu Qian, Paul S. S Aisen, Christine M. Albert, William J. Aronson et al. · 2026 · Proceedings of The Nutrition Society
  89. Agreement Between Mega-Trials and Smaller Trials
    Lum Kastrati, Hamidreza Raeisi‐Dehkordi, Erand Llanaj, Hugo G. Quezada‐Pinedo, Farnaz Khatami, Noushin Sadat Ahanchi, Adea Llane, Renald Meçani, Taulant Muka, John P. A. Ioannidis · 2024 · JAMA Network Open
  90. Assessing Health and Economic Benefits of Omega-3 Fatty Acid Supplementation on Cardiovascular Disease in the Republic of Korea
    Moon Seong Kim, Jin‐Man Kim, Sang Gyeong Lee, Eun-Jin Jung, Sang Hoon Lee, Wen Yan Huang, Bok Kyung Han, Da Eun Jung, Sung Bum Yang, Inbae Ji et al. · 2023 · Healthcare
  91. Zur Überschätzung des Nutzens von Prävention
    Ingrid Mühlhauser · 2014 · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen
  92. Update on Ischemic Heart Disease and Critical Care Cardiology
    Francisco R. Marín, Óscar Dı́az-Castro, Juan M. Ruiz-Nodar, Bernardo García de la Villa, Alessandro Sionís, Javier López, Antonio Fernández‐Ortíz, Manuel Martínez‐Sellés · 2014 · Revista Española de Cardiología (English Edition)
  93. Dyslipidemia in Obesity
    Dick C. Chan, Jing Pang, Gerald Francis Watts · 2015 · Springer eBooks
  94. Molecular mechanisms underlying effects of n−3 and n−6 fatty acids in cardiovascular diseases
    Denny Joseph Manual Kollareth, Chuchun L. Chang, Hylde Zirpoli, Richard Joseph Deckelbaum · 2020 · Elsevier eBooks
  95. Chapter 4. Lifestyle modifications
    2014 · Hypertension Research
  96. Association of dietary fats with ischemic heart disease (IHD): a case–control study
    Mobina Zeinalabedini, Maryam Ladaninezhad, Khadijeh Abbasi Mobarakeh, Anahita Hoshiar-Rad, Soheila Shekari, Seyed Ali Askarpour, Naeemeh Hassanpour Ardekanizadeh, Mina Esmaeili, Morteza Abdollahi, Saeid Doaei et al. · 2024 · Journal of Health Population and Nutrition
  97. Dietary Fish Oil Concentrates Associated Health Benefits: A Recent Development of Cardiovascular Risk Reduction
    Sudhanshu S. Behera · 2019 · Current Pharmaceutical Design
  98. Effects of dietary n-3 polyunsaturated fatty acids on cardiovascular disease
    Kazuo Yamagata · 2020 · Studies in natural products chemistry
  99. ω-3 Fatty Acids and Lutein + Zeaxanthin Supplementation for the Prevention of Cardiovascular Disease
    Evangelos C. Rizos, Evangelia Ntzani · 2014 · JAMA Internal Medicine
  100. Is fish oil supplementation effective on maternal serum FBS, oral glucose tolerance test, hemoglobin and hematocrit in low risk pregnant women? A triple-blind randomized controlled trial
    Leila Vahedi, Alireza Ostadrahimi, Fatemeh Edalati-Fard, Hossein Aslani, Azizeh Farshbaf‐Khalili · 2018 · Journal of Complementary and Integrative Medicine